
Title: New delivery method cuts required dose, promises relief from adverse side effects of antipsychotic medication Article Link

Title: Researchers receive DOD funding to expand study of investigational drug to prevent ARDS in COVID-19 patients Article Link
Title: Repeated Ketamine Infusions Reduce Symptom Severity in Individuals With Chronic Post-Traumatic Stress Disorder
Article Link

Title: International Trials of Blood Thinners in Critically Ill COVID-19 Patients Pause Due to Futility Article Link

Title: DARPA and JPEO-CBRND Award $37.6M to The Wistar Institute and Collaborators at INOVIO, AstraZeneca, Penn, & Indiana University to Develop Innovative COVID-19 Treatment Article Link